Newton, K <br/><br/>
Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC).  [electronic resource] 

 -  Journal of medical genetics  Dec 2014 
 - 789-96 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-6244 
<br/><br/><label>Standard No.: </label>10.1136/jmedgenet-2014-102552  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing--genetics<br/>Adult<br/>Alleles<br/>Brain Neoplasms--genetics<br/>Colorectal Neoplasms--genetics<br/>Colorectal Neoplasms, Hereditary Nonpolyposis--diagnosis<br/>CpG Islands<br/>DNA Methylation<br/>Genetic Testing--methods<br/>Heterozygote<br/>Humans<br/>Middle Aged<br/>MutL Protein Homolog 1<br/>Mutation<br/>Neoplasms--genetics<br/>Neoplastic Syndromes, Hereditary--genetics<br/>Nuclear Proteins--genetics<br/>Promoter Regions, Genetic<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Sensitivity and Specificity